In a report released yesterday, Michael Ulz from Morgan Stanley reiterated a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), ...
Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Xerox Holdings Corporation ("Xerox" or the "Company") (NASDAQ: XRX). Such investors are advised ...
It's no secret that the venture capital industry is facing a liquidity crisis as IPOs and other exits remain few and far ...
Analysts Predict a $102 Target for Viking Therapeutics Inc (VKTX) Stock—What Could Drive It There?
On Friday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $49.58 which represents a decrease of $-3.99 or -7.45% from the prior close of $53.57. The stock opened at $53.18 and ...
Calie Lewis, the owner of Classical Pilates at 15583 S. Dixie Hwy in Monroe, talks about classes offered and how to book.
There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback